Cognition, Olfaction and Uric Acid in Early de novo Parkinson's Disease
- Author:
Hwa Reung LEE
1
;
Joong Hyun PARK
;
Sang Won HAN
;
Jong Sam BAIK
Author Information
- Publication Type:Original Article
- Keywords: Cognition; Parkinson's disease; olfaction; uric acid
- MeSH: Cognition Disorders; Cognition; Discrimination (Psychology); Female; Humans; Male; Odors; Parkinson Disease; Risk Factors; Smell; Uric Acid
- From:Journal of Movement Disorders 2018;11(3):139-144
- CountryRepublic of Korea
- Language:English
- Abstract: OBJECTIVE: Cognitive impairment is one of the nonmotor symptoms in Parkinson's disease (PD), and olfactory dysfunction is used as a marker to detect premotor stages of PD. Serum uric acid (sUA) levels have been found to be a risk factor for PD. Our objective in this study was to examine whether sUA levels are associated with cognitive changes and olfactory dysfunction in early de novo PD patients. METHODS: The study participants included 196 de novo PD patients. We assessed cognitive function by the Korean versions of the Mini-Mental State Examination and the Montreal Cognitive Assessment and assessed olfactory function by the Korean version of the Sniffin' Sticks test. RESULTS: The mean sUA level was 4.7 mg/dL and was significantly lower in women than in men. Cognitive scores were lower in women, suggesting that sUA levels were related to cognitive function. The olfactory functions were not related to sUA level but were clearly associated with cognitive scores. Olfactory threshold, odor discrimination, and odor identification were all significantly related to cognitive scores. CONCLUSIONS: We conclude that lower sUA levels were associated with cognitive impairment, not olfactory dysfunction, in de novo PD patients. This finding suggests that UA is neuroprotective as an antioxidant in the cognitive function of PD patients.
